Upcoming Event September 14, 2022
FDA Safety Communications
December 17, 2021
Learn More
FDA Advisory Committee Meetings
Learn More
Latest Publications & Presentations
Publication
08/16/2022
The incidence of arterial thromboembolism and venous thromboembolism in persons with COVID-19 remains unclear. The objective of this study was to measure the 90-day risk of arterial…
Publication
07/24/2022
It is a priority of the US Food and Drug Administration (FDA) to monitor the safety of medications used during pregnancy. Pregnancy exposure registries and cohort studies utilizing electronic…
